COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 1803: Articles 18021-18030  | Next

Retinol Depletion in Severe COVID-19
Sarohan, A. R., Akelma, H., Arac, E., Aslan, O.
10.1101/2021.01.30.21250844 — Posted: 2021-02-01 Discussion: Onsite
MOATAI-VIR - an AI algorithm that predicts severe adverse events and molecular features for COVID-19's complications
Astore, C. A., Zhou, H., Jacob, J., Skolnick, J.
10.1101/2021.01.29.21250712 — Posted: 2021-02-01
A mathematical model to estimate percentage secondary infections from margin of error of diagnostic sensitivity: Useful tool for regulatory agencies to assess the risk of propagation due to false negative outcome of diagnostics
Palavesam, A., Kumaragurubaran, K., R Parthiban, A. B., TMA, S., Chidambaram, B., Gopal, D. R.
10.1101/2021.01.29.21250804 — Posted: 2021-02-01
Discontinuation of isolation for persons with COVID-19: Is 10 days really safe?
Felix, A. C., Vincente de Paula, A., Ribeiro, A. C., da Silva, F. C., Inemami, M., Costa, A. A., Leal, C. O., Figueiredo, W. M., Pannuti, C. S., Romano, C. M.
10.1101/2021.01.29.21250753 — Posted: 2021-02-01
Estimating the COVID-19 Prevalence in Spain with Indirect Reporting via Open Surveys
Garcia-Agundez, A., Ojo, O., Hernandez, H., Baquero, C., Frey, D., Georgiou, C., Goessens, M., Lillo, R., Menezes, R., Nicolaou, N., Ortega, A., Stavrakis, E., Fernandez Anta, A.
10.1101/2021.01.29.20248125 — Posted: 2021-02-01
Updated SARS-CoV-2 Single Nucleotide Variants and Mortality Association
Fang, S., Liu, S., Shen, J., Lu, A. Z., Zhang, Y., Li, K., Liu, J., Yang, L., Hu, C.-D., Wan, J.
10.1101/2021.01.29.21250757 — Posted: 2021-02-01
Ultra-short-wave diathermy shortens the course of moderate and severe COVID-19: a randomized controlled trial
huang, l., li, q., Sayed, S. Z. A., Mohammad, N., chen, b., Iftikhar, M. A., Xie, L., Hu, J., chen, h.
10.1101/2021.01.28.21250163 — Posted: 2021-02-01
How best do we engage the general population in testing for COVID-19?
Watson, D., Laverty Baralle, N., Alagil, J., Anil, K., Ciccognani, S., Dewar-Haggart, R., Fearn, S., Groot, J., Knowles, K., Meagher, C., McGrath, C., Muir, S., Musgrove, J., Glyn-Owen, K., Woods-Townsend, K., Mortimore, A., Roderick, P., Baird, J., Inskip, H., Godfrey, K., Barker, M.
10.1101/2021.01.29.21250730 — Posted: 2021-02-01
COVID-19 Prevention Beliefs and Practices in College Students
Cassimatis, C., Kreitner, L., Njai, A., Leary, E., Gray, A. D.
10.1101/2021.01.29.21250794 — Posted: 2021-02-01
COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout
Barry, M., Temsah, M.-H., Aljamaan, F., Saddik, B., Al-Eyadhy, A., Alanazi, S., Alamro, N., Alhuzaimi, A., Alhaboob, A., Alsohime, F., Alaraj, A., Halwani, R., Jamal, A., Temsah, O., Alzamil, F., Alsomialy, A., Al-Tawfiq, J.
10.1101/2021.01.29.21250749 — Posted: 2021-02-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).